In the context of increasing attention by world leaders to 'debt for equity' exchanges, and economic restructuring that will both repair and redress the increasing stratification of world trade, two questions become especially prominent: how can past exploitations be repaid, and how can their reproduction be prevented in the future? As argued in a recent Channel Four documentary, ' The empire pays back', a considerable proportion of the wealth and wealth accumulating enterprises which account for the global economic privilege enjoyed by modern nations such as Britain derive, historically, from vast appropriations of resources, often from tropical, colonial territories. A major worry in the context of the new 'bio-economies' of the postgenomic 'race' to gain global market shares in new industries such as recombinant DNA technologies is whether yet another chapter in the ' Frequently on the move, Hayden's research took her to artisans' collectives where the agave cactus is pit-roasted to make mescal, and up dry arroyos to hidden ranch-houses in old copper mines to find the old and new natures being forged out of indigenous knowledge and native plant resources. She also spent time in museums and in laboratories, and went shopping at traditional Mexican markets, as well as collecting samples along roadsides and in 'disturbed areas' burnt by forest fires, always accompanying her ethnobotanical biologos on their quest to discover new sources of potentially marketable biocapital. Her clippers never far from her hand, she gets all mixed up in the complicated business of botanical bioprospecting and the elusive quest to find 'isolated compounds that ostensibly can be shown to have discrete kinds of efficacy' (p. 194). For Hayden, all of this movement is a crucial indicator that plant resources must be made, as well as found: by being given new kinds of 'connection' a bioactive plant extract can be reanimated as a commercial product.
As Hayden notes in her superb overview of debates about patenting 'life itself', these movements and mixtures are what define the geography of bioprospecting, hybridizing scientific and indigenous knowledges, abstract nomenclature and venture capital, and 'bioactivities' with the technologies that can extract them. After all, property is always a mixture: a containment strategy 'sutured together', to use a phrase Hayden returns to as a refrain throughout, out of legal entitlements, individual identities, national constitutions and conceptual legacies. Property is itself the product of a paradoxical process, a reification which must be as fluid as it must be stable -a bit like the biological itself.
The fluidity, but intractability, both of the biological and its properties and of the power that is needed to give these a stable economic shape, is the idea that unites both of these books, which each offer timely and insightful analyses of the contested relationship between biological collection and its commodification. Bronwyn Parry's economic geography of biological trade begins in the unlikely location of Frederick, Maryland, at the Natural Products Repository of the US National Cancer Institute. Here, in 'a wholly unremarkable brown warehouse' in a rural backwater are stored more than 50000 different samples of plants, animals For Cori Hayden, following the biological action in the world of bioprospecting can usefully be seen in terms of what she describes as 'unexpected webs of accountability'. As both Hayden and Parry show, most of the biologically desirable resources are in the economically deprived south, now, as in the past, the source of most of the world's valuable 'tropilogicals'. But, as both authors also discuss in depth, the efforts made by many countries, governments and NGOS, through conventions, treaties, corporate policies and local governance, to benefit share are much more easily agreed in principle than they are to carry out.
In fact, one of the most important scholarly and intellectual legacies of these two books put together is their combined diagnosis of what is wrong with the idea of benefit sharing, and why -despite the fact that everyone agrees with the principle of reciprocity enshrined in documents such as the 1992 For Parry, an important remedy can be found in the form of duty -both in the moral and financial sense, indeed, where they meet. While some already powerful national economies are in a position to capitalize on what she calls the 'brave new bioinformational economy', others are not, and this is how age-old inequalities based on being bio-rich and bio-poor will once again be widened through the process of 'remining' of the biological as the informatic. Hence, while it is reported that pharmaceutical companies are estimated to earn between $75 and $150 billion annually from natural materials sourced primarily from developing countries, none of these countries has ever received any significant redistributed income from these markets.
A duty, or levy, on all products sourced in this way of 3 to 5 per cent would clearly reverse such a tendency, and would avoid the baroque complexity of product traceability exhaustively documented by both of these books, and ultimately diagnosed by them as chronically infirm. Such simple solutions are surely within reach of a society capable of mapping the human genome and reproducing it on a CD. On the other hand, these books both demonstrate the depth of conflict between the drive to accumulate wealth and the desire to distribute it more equitably. Appearing at a crucial moment when the effort to repay past debts is at a high point of public visibility, and yet another round of 'bio-extraction' is already under way, these two books offer invaluable perspectives that reveal the making of biowealth from the inside out.
Notes
